JP2011515409A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2011515409A5 JP2011515409A5 JP2011500916A JP2011500916A JP2011515409A5 JP 2011515409 A5 JP2011515409 A5 JP 2011515409A5 JP 2011500916 A JP2011500916 A JP 2011500916A JP 2011500916 A JP2011500916 A JP 2011500916A JP 2011515409 A5 JP2011515409 A5 JP 2011515409A5
- Authority
- JP
- Japan
- Prior art keywords
- compound
- formula
- pharmaceutically acceptable
- acceptable salt
- composition
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
- 150000001875 compounds Chemical class 0.000 claims 15
- 150000003839 salts Chemical class 0.000 claims 11
- 229910052760 oxygen Inorganic materials 0.000 claims 2
- 229910052717 sulfur Inorganic materials 0.000 claims 2
- 201000004384 Alopecia Diseases 0.000 claims 1
- 208000010412 Glaucoma Diseases 0.000 claims 1
- 206010030043 Ocular hypertension Diseases 0.000 claims 1
- 125000000217 alkyl group Chemical group 0.000 claims 1
- 231100000360 alopecia Toxicity 0.000 claims 1
- 125000004432 carbon atom Chemical group C* 0.000 claims 1
- 230000003779 hair growth Effects 0.000 claims 1
- 238000004519 manufacturing process Methods 0.000 claims 1
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims 1
- 230000004936 stimulating effect Effects 0.000 claims 1
- 0 C[C@@](CNC1(CCC1)N)[C@@]1[C@@](CCCc2ccc(*)[n]2)[C@@](*)C[C@]1* Chemical compound C[C@@](CNC1(CCC1)N)[C@@]1[C@@](CCCc2ccc(*)[n]2)[C@@](*)C[C@]1* 0.000 description 2
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US3762208P | 2008-03-18 | 2008-03-18 | |
| US61/037,622 | 2008-03-18 | ||
| US12/405,349 | 2009-03-17 | ||
| US12/405,349 US7960378B2 (en) | 2008-03-18 | 2009-03-17 | Therapeutic compounds |
| PCT/US2009/037477 WO2009117467A2 (en) | 2008-03-18 | 2009-03-18 | Therapeutic compounds |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2011515409A JP2011515409A (ja) | 2011-05-19 |
| JP2011515409A5 true JP2011515409A5 (https=) | 2012-05-17 |
Family
ID=41089556
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2011500916A Ceased JP2011515409A (ja) | 2008-03-18 | 2009-03-18 | 治療用化合物 |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US7960378B2 (https=) |
| EP (1) | EP2279169A2 (https=) |
| JP (1) | JP2011515409A (https=) |
| AU (1) | AU2009225693B2 (https=) |
| BR (1) | BRPI0909764A2 (https=) |
| CA (1) | CA2718713A1 (https=) |
| WO (1) | WO2009117467A2 (https=) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2303836A1 (en) * | 2008-05-09 | 2011-04-06 | Allergan, Inc. | Therapeutic cyclopentane derivatives |
| US8299068B2 (en) * | 2010-01-29 | 2012-10-30 | Allergan, Inc. | Therapeutically active cyclopentanes |
| JP6626831B2 (ja) * | 2014-02-20 | 2019-12-25 | アラーガン、インコーポレイテッドＡｌｌｅｒｇａｎ，Ｉｎｃｏｒｐｏｒａｔｅｄ | ベータ−クロロシクロペンタンの親水性エステルプロドラッグの使用による角膜中心肥厚の減少 |
| CN111018826B (zh) * | 2019-12-25 | 2020-11-10 | 西华大学 | 2-氰基-5-氧代戊酸乙酯类化合物及其应用 |
Family Cites Families (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3013A (en) * | 1843-03-21 | James stewabt | ||
| US7027A (en) * | 1850-01-15 | Circulak | ||
| US4166452A (en) * | 1976-05-03 | 1979-09-04 | Generales Constantine D J Jr | Apparatus for testing human responses to stimuli |
| US4256108A (en) * | 1977-04-07 | 1981-03-17 | Alza Corporation | Microporous-semipermeable laminated osmotic system |
| US4265874A (en) * | 1980-04-25 | 1981-05-05 | Alza Corporation | Method of delivering drug with aid of effervescent activity generated in environment of use |
| GB8329559D0 (en) | 1983-11-04 | 1983-12-07 | Erba Farmitalia | Furyl derivatives of 16-substituted prostaglandins preparations |
| US5288754A (en) * | 1992-02-04 | 1994-02-22 | Allergan, Inc. | Polar C-1 esters of prostaglandins |
| US5476872A (en) * | 1993-10-18 | 1995-12-19 | Allergan, Inc. | 1,11-diesters of prostaglandin-F2α having a polar ester group at C-1 |
| JP3162668B2 (ja) * | 1997-02-04 | 2001-05-08 | 小野薬品工業株式会社 | ω−シクロアルキル−プロスタグランジンＥ２誘導体 |
| NO317155B1 (no) * | 1997-02-04 | 2004-08-30 | Ono Pharmaceutical Co | <omega>-cykloalkyl-prostagladin-E<N>2</N>-derivater |
| US6437146B1 (en) * | 1998-09-25 | 2002-08-20 | Fujisawa Pharmaceutical Co., Ltd. | Oxazole compounds as prostaglandin e2 agonists or antagonists |
| US6376533B1 (en) * | 2000-10-20 | 2002-04-23 | Allergan Sales, Inc. | Omega-cycloalkyl 17-heteroaryl prostaglandin E2 analogs as EP2-receptor agonists |
| US6410591B1 (en) * | 2001-05-08 | 2002-06-25 | Allergan Sales, Inc. | 3,7 or 3 and 7 thia or oxa prostanoic acid derivatives as agents for lowering intraocular pressure |
| NZ532519A (en) * | 2001-11-05 | 2006-11-30 | Allergan Inc | Omega-cycloalkyl 17-heteroaryl prostaglandin E2 analogs as EP2-receptor agonists |
| EP1812017A2 (en) * | 2004-10-21 | 2007-08-01 | Duke University | Ophthamological drugs |
| WO2006096179A1 (en) | 2005-03-07 | 2006-09-14 | Carrier Corporation | Compressor sound suppression |
| US20070254920A1 (en) * | 2006-04-26 | 2007-11-01 | Aerie Pharmaceuticals, Inc. | Prodrug derivatives of acids using alcohols with homotopic hydroxy groups and methods for their preparation and use |
| US7547727B2 (en) * | 2006-05-22 | 2009-06-16 | Allergan, Inc. | Therapeutic cyclopentane derivatives |
| PL2084124T3 (pl) | 2006-10-02 | 2014-08-29 | Techfields Biochem Co Ltd | Dodatnio naładowane rozpuszczalne w wodzie proleki prostaglandyn i związków pokrewnych o bardzo dużych szybkościach przenikania przez skórę |
| US8193373B2 (en) | 2006-12-11 | 2012-06-05 | Allergan, Inc. | Therapeutic compounds |
-
2009
- 2009-03-17 US US12/405,349 patent/US7960378B2/en active Active
- 2009-03-18 AU AU2009225693A patent/AU2009225693B2/en not_active Ceased
- 2009-03-18 WO PCT/US2009/037477 patent/WO2009117467A2/en not_active Ceased
- 2009-03-18 EP EP09721753A patent/EP2279169A2/en not_active Withdrawn
- 2009-03-18 CA CA2718713A patent/CA2718713A1/en not_active Abandoned
- 2009-03-18 JP JP2011500916A patent/JP2011515409A/ja not_active Ceased
- 2009-03-19 BR BRPI0909764A patent/BRPI0909764A2/pt not_active IP Right Cessation
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2011518833A5 (https=) | ||
| JP2013537203A5 (https=) | ||
| JP2014520898A5 (https=) | ||
| JP2012500805A5 (https=) | ||
| JP2010524932A5 (https=) | ||
| EP2620432A3 (en) | Diarylhydantoin compounds | |
| JP2011522827A5 (https=) | ||
| JP2012006970A5 (https=) | ||
| AR047972A1 (es) | Derivado de bencimidazol, proceso de obtencion y composiciones farmaceuticas. | |
| JP2015521167A5 (https=) | ||
| JP2013512277A5 (https=) | ||
| JP2009541216A5 (https=) | ||
| JP2013513613A5 (https=) | ||
| JP2009507909A5 (https=) | ||
| JP2011006480A5 (https=) | ||
| JP2008539268A5 (https=) | ||
| JP2009539828A5 (https=) | ||
| JP2013542261A5 (https=) | ||
| JP2012530758A5 (https=) | ||
| JP2019513745A5 (https=) | ||
| JP2017514910A5 (https=) | ||
| JP2010510232A5 (https=) | ||
| JP2015508092A5 (https=) | ||
| JP2011515409A5 (https=) | ||
| JP2014516033A5 (https=) |